1 / 6

Narcolepsy Pipeline Therapeutics Assessment Review H1 2015

The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities.

john2222deere
Download Presentation

Narcolepsy Pipeline Therapeutics Assessment Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Narcolepsy - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Markets Direct Date: 20-May-2015 No. of pages: 59 Single User License: US $2000 Browse more Reports on Neurology Therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Narcolepsy - Pipeline Review, H1 2015 This report gives extensive data on the helpful improvement for Narcolepsy, complete with near investigation at different stages, therapeutics appraisal by medication target, instrument of activity (MoA), course of organization (RoA) and particle sort, alongside most recent overhauls, and included news and press discharges. It additionally audits key players included in the helpful improvement for Narcolepsy and exceptional elements on late-stage and stopped undertakings. The report upgrades choice making abilities and help to make viable counter methods to increase game changer. It reinforces R&D pipelines by recognizing new targets and MOAs to create first-in-class and best-in-class items. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Narcolepsy - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research : Bioprojet SCR, Evotec AG, Flamel Technologies S.A., Grupo Ferrer Internacional, S.A., Jazz Pharmaceuticals plc, SK Biopharmaceuticals Co., Ltd., and Taisho Pharmaceutical Co., Ltd. Drugs Profile Discussed in this Research : arbaclofen, Drugs to Agonize Orexin Receptor for Narcolepsy, EVT-501, JZP-386, pitolisant, SKL-N05, Small Molecules to Agonize Orexin Receptor for Narcolepsy and EDS, Small Molecules to Inhibit Dopamine Transporter for CNS and Metabolic Disorders, sodium oxybate, sodium oxybate, THN-102 and TS-091. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Narcolepsy - Pipeline Review, H1 2015 Scope For Narcolepsy - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Narcolepsy • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Narcolepsy and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Narcolepsy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages • A detailed assessment of monotherapy and combination therapy pipeline projects ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Narcolepsy - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Narcolepsy • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Narcolepsy pipeline depth and focus of Indication therapeutics • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Narcolepsy - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related